A nurse is caring for a client who is receiving total parenteral nutrition (TPN). ?The nurse identifies which of the following as a complication of TPN?
Magnesium 1.1 ( 1.3 to 2.1? )
Triglycerides 35 (40 to 160 )
Phosphorous 4.8 ( 3 to 4.5 )
Alkaline Phosphatase (ALP) 25 units/L (30 to 120 units/L)
The Correct Answer and Explanation is :
The correct answer is Alkaline Phosphatase (ALP) 25 units/L.
Explanation:
Total Parenteral Nutrition (TPN) provides essential nutrients intravenously to clients who cannot receive adequate nutrition through oral or enteral routes. While TPN is a lifesaving intervention, it can be associated with several complications, especially when used over a long period. One of the potential complications is liver dysfunction, which is often reflected in abnormal liver enzyme levels, such as alkaline phosphatase (ALP).
- Alkaline Phosphatase (ALP) 25 units/L (Normal: 30 to 120 units/L):
- ALP is an enzyme found in various tissues, including the liver and bone. A decrease in ALP levels is less common but could indicate liver impairment, which is a known complication of TPN. Long-term TPN use can lead to liver dysfunction, which includes cholestasis (impaired bile flow) and steatosis (fatty liver), contributing to changes in liver enzyme levels.
- TPN can affect the liver due to factors such as hyperglycemia, the infusion of high amounts of lipids, and reduced biliary secretion. In some cases, ALP levels may decrease as part of overall liver enzyme suppression or biliary obstruction.
- Magnesium 1.1 (Normal: 1.3 to 2.1):
- Low magnesium levels (hypomagnesemia) can occur in patients receiving TPN due to malabsorption, excessive renal loss, or inadequate supplementation in the TPN formulation. However, this particular magnesium level is mildly low and would not necessarily be classified as a major complication specific to TPN itself, though it requires monitoring and potential supplementation.
- Triglycerides 35 (Normal: 40 to 160):
- Triglycerides within the range of 35 mg/dL are generally considered within acceptable limits. However, hypertriglyceridemia is a known complication of TPN, especially in patients who receive high lipid infusions. Monitoring is important, but this level is not indicative of a complication at this time.
- Phosphorus 4.8 (Normal: 3 to 4.5):
- Phosphorus levels that slightly exceed the normal range (4.8) can occur in patients on TPN, especially if there is renal impairment or an imbalance in electrolytes. However, this level is not substantially elevated and would not be considered a major complication of TPN administration.
In summary, decreased ALP levels are the most notable finding in this case and suggest potential liver dysfunction, which can be a significant complication of long-term TPN therapy.